Clinical trial
Safety and Efficacy of Immune Therapy for Condyloma
NCT03158480 is registered in ClinicalTrials.gov with Shenzhen Second People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Immune Therapy for Condyloma
- Lead sponsor
- Shenzhen Second People's Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 25, 2017
- Completion date
- June 30, 2019
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.